CD 19‐Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia
Adoptive cell therapy ( ACT ) for cancer represents a promising new treatment modality. ACT based on the administration of cytotoxic T cells genetically engineered to express a chimeric antigen receptor ( CAR ) recognizing CD 19 expressed by B cell malignancies has been shown to induce complete last...
Gespeichert in:
| Veröffentlicht in: | Scandinavian journal of immunology 2015-10, Vol.82 (4), p.307-319 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!